HLS Therapeutics Inc (TSE:HLS) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
HLS Therapeutics Inc., a company specializing in psychiatric and cardiovascular treatments, will present at the upcoming H.C. Wainwright’s 26th Annual Global Investment Conference on September 11, 2024. Their CEO, Craig Millian, will not only present but also engage in one-on-one meetings with investors at the New York City event. The presentation will be accessible via webcast and later archived on the company’s website for 90 days.
For further insights into TSE:HLS stock, check out TipRanks’ Stock Analysis page.
